---
title: "奥麦罗制药 (OMER.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/OMER.US/norm.md"
symbol: "OMER.US"
name: "奥麦罗制药"
parent: "https://longbridge.com/zh-CN/quote/OMER.US.md"
datetime: "2026-05-19T21:45:10.812Z"
locales:
  - [en](https://longbridge.com/en/quote/OMER.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OMER.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OMER.US/norm.md)
---

# 奥麦罗制药 (OMER.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.6234 | 0.9771 | -0.4666 | -0.4340 | -0.5793 |
| ROE | -222.14% | -187.04% | 37.84% | 46.83% | 75.86% |
| 营业收入 | 9.89M | - | - | - | - |
| 净利润 | 56.06M | 86.45M | -30.92M | -25.42M | -33.46M |
| 营业利润 | -17.42M | -29.08M | -26.39M | -32.35M | -34.97M |
| 毛利率 | 54.34% | - | - | - | - |
| 净利率 | 566.66% | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 286.17M | 325.63M | 185.71M | 200.57M | 235.16M |
| 权益乘数 | -4.52 | -2.69 | -0.8423 | -0.8771 | -1.10 |
| 每股净资产 | -0.8797 | -1.69 | -3.15 | -3.81 | -3.68 |
| 资产周转率 | 0.0380 | - | - | - | - |
| 现金及短投 | 135.32M | 171.80M | 36.09M | 28.74M | 52.41M |
| 存货与应收 | 183000.00 | - | - | - | - |
| 长期投资 | 11.05M | 12.48M | 13.82M | 15.13M | 16.37M |
| 净债务 | 91.29M | 78.03M | 327.35M | 353.27M | 362.64M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -14.51M | -39.84M | -18.47M | -21.94M | -35.84M |
| 投资现金流 | 28.73M | 111.55M | -6.86M | 21.30M | 38.54M |
| 融资现金流 | -21.98M | -64.44M | 25.82M | -1.72M | -1.84M |
| 自由现金流 | -10.92M | 211.56M | -13.64M | -1.53M | -21.68M |
| 现金流充裕率 | -84.04% | -59.24% | -9826.06% | -9750.22% | -16217.65% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | 0.0000 | -11000.00 | -13000.00 | -41000.00 |